Good trial results for presbyopia treatment

As reported previously (Sep 2018) Israel’s Orasis has developed CSF-1 (eye drops) to treat presbyopia – age-related far-sightedness. Results of Phase 2b trials of CSF-1 showed “significant improvement”, together with “exceptional safety and tolerability”.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *